FindTrial
Sign In

Evaluating the Effects of Intraoperative Intravitreal Triamcinolone Acetonide on Visual Outcomes and Postoperative Recovery in Uveitic Cataract Patients Undergoing SICS

A study on the impact of intraoperative Intravitreal Triamcinolone Acetonide injection on visual outcome, postoperative complications and visual rehabilitation in patients of uveitic cataract undergoing SICS - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073833
Enrollment
30
Registered
2024-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H22- Disorders of iris and ciliary bodyin diseases classified elsewhere

Interventions

Intervention1: Intravitreal Triamcinolone Acetonide injection: 3 mg/ml (0.075ML)Triamcinolone Acetonide Intravitreal injection is given intraoperatively once and the patient is followed up for 1 year.

Sponsors

Moti Lal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1.Diagnosis of uveitis consistent with Standardization Uveitis Nomenclature (SUN). 2.Intraocular inflammation had been controlled without using topical or oral corticosteroid for atleast 3 months before surgery .

Exclusion criteria

Exclusion criteria: Exclusion Criteria : 1.Infectious uveitis. 2. Previous intraocular surgery . 3.Patients with history of glaucoma or high myopia, optic neuropathy, media opacity other than cataract . 4.Patients less than 18 years or with juvenile rheumatoid arthritis. 5.Retinal or choroidal disease. 6.Intraoperative posterior capsular rupture or viterous loss.

Design outcomes

Primary

MeasureTime frame
1 visual acuity 2 Intraocular pressure 3 central Macular Thickness 4 Anterior Chamber reaction 5 endothelial cell density Timepoint: postoperative day 1 1 week 1 month 2 months 3 months 6 months—

Secondary

MeasureTime frame
postoperative complicationsTimepoint: postoperative day 1 1 week 1 month 2 months 3 months 6 months—

Countries

India

Contacts

Public ContactSANTOSH KUMAR

MOTI LAL NEHRU MEDICAL COLLEGE

drsantosh7373@gmail.com9412247373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026